Methylated PTGER4 is better than CA125, CEA, Cyfra211 and NSE as a therapeutic response assessment marker in stage IV lung cancer

Real-time assessment of therapeutic response in patients with advanced lung cancer presents a major challenge throughout the treatment process. Currently, computed tomography imaging is often used; however, it is radiation-based and hysteretic and is not suitable for repeated use as a real-time asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yunxia, Huang, Jianfeng, Zou, Qinzhou, Che, Jun, Yang, Kaihua, Fan, Qiang, Qian, Danqi, Wu, Jia, Bao, Erwen, Song, Lele, Zhang, Fuzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074558/
https://www.ncbi.nlm.nih.gov/pubmed/32256818
http://dx.doi.org/10.3892/ol.2020.11434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074558/
https://www.ncbi.nlm.nih.gov/pubmed/32256818
http://dx.doi.org/10.3892/ol.2020.11434

Ejemplares similares